Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial

M.M. Nijkamp, P.N. Span, C.H.J. Terhaard, P.A.H. Doornaert, J.A. Langendijk, P.L.A. van den Ende, M. de Jong, A.J. van der Kogel, J. Bussink, J.H.A.M. Kaanders

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3202-3209
JournalEuropean Journal of Cancer
Volume49
Issue number15
DOIs
Publication statusPublished - 2013

Cite this

Nijkamp, M. M., Span, P. N., Terhaard, C. H. J., Doornaert, P. A. H., Langendijk, J. A., van den Ende, P. L. A., ... Kaanders, J. H. A. M. (2013). Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial. European Journal of Cancer, 49(15), 3202-3209. https://doi.org/10.1016/j.ejca.2013.06.024
Nijkamp, M.M. ; Span, P.N. ; Terhaard, C.H.J. ; Doornaert, P.A.H. ; Langendijk, J.A. ; van den Ende, P.L.A. ; de Jong, M. ; van der Kogel, A.J. ; Bussink, J. ; Kaanders, J.H.A.M. / Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial. In: European Journal of Cancer. 2013 ; Vol. 49, No. 15. pp. 3202-3209.
@article{7341d2144d50404ead13ce3a2b09ff31,
title = "Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial",
author = "M.M. Nijkamp and P.N. Span and C.H.J. Terhaard and P.A.H. Doornaert and J.A. Langendijk and {van den Ende}, P.L.A. and {de Jong}, M. and {van der Kogel}, A.J. and J. Bussink and J.H.A.M. Kaanders",
year = "2013",
doi = "10.1016/j.ejca.2013.06.024",
language = "Undefined/Unknown",
volume = "49",
pages = "3202--3209",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Pergamon",
number = "15",

}

Nijkamp, MM, Span, PN, Terhaard, CHJ, Doornaert, PAH, Langendijk, JA, van den Ende, PLA, de Jong, M, van der Kogel, AJ, Bussink, J & Kaanders, JHAM 2013, 'Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial' European Journal of Cancer, vol. 49, no. 15, pp. 3202-3209. https://doi.org/10.1016/j.ejca.2013.06.024

Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial. / Nijkamp, M.M.; Span, P.N.; Terhaard, C.H.J.; Doornaert, P.A.H.; Langendijk, J.A.; van den Ende, P.L.A.; de Jong, M.; van der Kogel, A.J.; Bussink, J.; Kaanders, J.H.A.M.

In: European Journal of Cancer, Vol. 49, No. 15, 2013, p. 3202-3209.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial

AU - Nijkamp, M.M.

AU - Span, P.N.

AU - Terhaard, C.H.J.

AU - Doornaert, P.A.H.

AU - Langendijk, J.A.

AU - van den Ende, P.L.A.

AU - de Jong, M.

AU - van der Kogel, A.J.

AU - Bussink, J.

AU - Kaanders, J.H.A.M.

PY - 2013

Y1 - 2013

U2 - 10.1016/j.ejca.2013.06.024

DO - 10.1016/j.ejca.2013.06.024

M3 - Article

VL - 49

SP - 3202

EP - 3209

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 15

ER -